Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating cerebral thrombosis and preparation method thereof

A technology of composition and cerebral thrombosis, applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve problems such as ineffectiveness

Inactive Publication Date: 2017-05-31
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[Pharmacological Actions] 1. Asthma-relieving effect: GONG Artemisia seed oil (Caraway oil) mainly contains d-carawayone, which has anti-asthmatic effect (guinea pig histamine method); has antitussive effect on mice (ammonia water method) ), but it has no effect on the cough caused by electrical stimulation of the superior laryngeal nerve in cats, so it has no effect on the cough center

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Embodiment 1: The pharmaceutical composition and preparation method thereof for the treatment of cerebral thrombosis

[0037] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating cerebral thrombosis are as follows: 4700 parts by weight of medical stone, 6900 parts by weight of Shilian, 3600 parts by weight, 3600 parts by weight, 2200 parts by weight, anisodine, 160 parts by weight, isodecanal 107 parts by weight;

[0038] Preparation:

[0039] (1) According to the ratio of raw materials, take Maifan stone, Echeveria chinensis, Sherbetia chinensis, Tibetan fennel, anisodine, and isodecanal, mix them evenly, use ethanol with a concentration of 32% by weight as a solvent, and soak at 54°C Extraction, the number of times of extraction is 8 times, each extraction time is 24 hours, and the amount of solvent is 48 times of the total weight of the raw material drug each time, and is filtered to obtain medicinal residue A a...

Embodiment 2

[0042] Embodiment 2: the pharmaceutical composition for the treatment of cerebral thrombosis and its preparation method

[0043] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating cerebral thrombosis are as follows: 4650 parts by weight of medical stone, 6950 parts by weight of Shilian, 3550 parts by weight, 2250 parts by weight of Tibetan fennel, 155 parts by weight of anisodine, 112 parts by weight of isodecanal parts by weight;

[0044] Preparation:

[0045] (1) According to the ratio of raw materials, take Maifan stone, Echeveria chinensis, Sherbetia chinensis, Tibetan fennel, anisodine, and isodecanal, mix them evenly, use ethanol with a concentration of 32% by weight as a solvent, and soak at 54°C Extraction, the number of times of extraction is 8 times, each extraction time is 24 hours, and the amount of solvent is 48 times of the total weight of the raw material drug each time, and is filtered to obtain medicina...

Embodiment 3

[0048] Embodiment 3: the pharmaceutical composition for the treatment of cerebral thrombosis and its preparation method

[0049] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating cerebral thrombosis are as follows: 4750 parts by weight of medical stone, 6850 parts by weight of Shilian, 3650 parts by weight, 2150 parts by weight of Tibetan fennel, 165 parts by weight of anisodine, 102 parts by weight of isodecanal parts by weight;

[0050] Preparation:

[0051] (1) According to the ratio of raw materials, take Maifan stone, Echeveria chinensis, Sherbetia chinensis, Tibetan fennel, anisodine, and isodecanal, mix them evenly, use ethanol with a concentration of 32% by weight as a solvent, and soak at 54°C Extraction, the number of times of extraction is 8 times, each extraction time is 24 hours, and the amount of solvent is 48 times of the total weight of the raw material drug each time, and is filtered to obtain medicina...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
flash pointaaaaaaaaaa
densityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicine composition for treating cerebral thrombosis and a preparation method thereof. The medicine composition is prepared by taking maifanite, seeds of white flower cacalia, caesalpinia minax, fruits of caraway, anisodine and isocapric aldehyde as crude drugs through matching. The medicine composition disclosed by the invention can be prepared into various preparation forms according to a conventional preparation technology, and the treatment effect in treating the cerebral thrombosis is remarkable.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating cerebral thrombosis and a preparation method thereof. Background technique [0002] Cerebral thrombosis is called cerebral apoplexy or cerebral apoplexy in traditional Chinese medicine. According to survey statistics in recent years, about 75% of the surviving patients left different degrees of hemiplegia. The disease mainly occurs in the elderly, and it is mostly caused by deficiency of qi and blood, loss of work and rest, and improper diet, leading to endogenous phlegm turbidity, stagnation of qi, tinea of ​​blood, and blockage of veins. At present, the treatment of cerebral thrombosis is mainly based on "replenishing qi and activating blood circulation, removing blood stasis and dredging collaterals, eliminating phlegm and resuscitation", but the effect is not good. [0003] Medical stone: Quartz monzonite porph...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/48A61P9/10A61P7/02A61K33/00A61K31/11A61K31/439
CPCA61K31/11A61K31/439A61K33/00A61K36/23A61K36/48A61K2236/333A61K2236/39A61K2236/51A61K2236/55A61K2300/00
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com